Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-16
1997-05-13
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514338, 514450, A61K 3143, A61K 3144, A61K 31335
Patent
active
056293054
ABSTRACT:
A synergistic pharmaceutical combination and composition are disclosed for the treatment of gastritis and peptic ulcer containing a therapeutic amount of a proton pump inhibitor such as e.g., omeprazole or lansoprazole, which increases intragastric pH, and a therapeutic amount of an acid degradable antibacterial compound such as a penicillin or a macrolide. In particular, the combination is directed to the treatment of infections caused by Helicobacter pylori by raising the bioavailability of acid degradable antibacterial compounds.
REFERENCES:
patent: 5013743 (1991-05-01), Iwahi et al.
patent: 5407688 (1995-04-01), Place
Czinn et al, Chemical Abstracts, vol. 105, No. 17, abstract #149590m, 1986.
Tzelepi et al, Biological Abstracts, vol. 93, No. 2, abstract #14092, 1992.
Londong et al, Biological Abstracts, vol. 92, No. 5, abstract #56565, 1991.
Inatomi et al, Chem. Abstracts, vol. 115, No. 3, abstract #22001w, 1991.
Graham et al, Biosis Abstract, BR41: 125113, 1991.
McDermott, et al., Science, The Absorption of Orally Administered Penicillin, Mar. 22, 1946, pp. 359-361.
McNulty, et al., Eur. J. Clin. Microbiol. Infect. Dis., Susceptibility of Clinical Isolates, Aug., 1988, pp. 566-569.
The Lancet, Clarithromycin and Omeprazole, vol. 340, Jul. 25, 1992, p. 239.
Goodwin, Worsley, Peptic Ulcer Disease, 1992, Current Science, 8:122-127.
Loo, Sherman, Matlow; Helicobacter pylori Infection, Anti-microbial Agents & Chemotherapy, May, 1992, pp. 1133-1135.
P. Unge, et al. "Does Omeprazole, 40 mg o.m. improve antimicrobial therapy directed towards gastric Campylobacter-pylori in patients . . . " Scandinavian Journal of Gastroenterology 1989, 24 (Suppl. 166) p. 184 (Abstract).
P. Unge, et al. "Does Omeprazole improve antimicrobial therapy directed towards gastric Campylobacter-pylori in patients with antral gastritis" Scandinavian Journal of Gastroenterology 1989, 24 (Suppl. 167) pp. 49-54 (Article).
"Which regimen for H pylori eradication?" SCRIP No. 1861, p. 23; Oct. 5, 1993.
S. Rune, "Helicobacter pylori, Peptic Ulcer Disease and Inhibition of Gastric Acid Secretion" Digestion 1992; 51 (Suppl. 1): 11-16.
Eek Arne T.
Sj ostrand Sven Erik
Astra Aktiebolag
Cintins Marianne M.
Jarvis William R. A.
LandOfFree
Synergistic combination of a substance with gastric acid secreti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic combination of a substance with gastric acid secreti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic combination of a substance with gastric acid secreti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385511